| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2554382A1 Compounds useful in therapy |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2552550A1 Piperidine derivatives as gcs inhibitors |
| 07/27/2005 | EP1556351A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 07/27/2005 | EP1556350A1 Process for the preparation of stabilizers for polymers |
| 07/27/2005 | EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1556046A1 Phenylpiperidines and phenylpyrrolidines as histamine h3 receptor modulators |
| 07/27/2005 | EP1556045A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1309555B1 Process for making amlodipine maleate |
| 07/27/2005 | EP1274411B1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 07/27/2005 | EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 07/27/2005 | CN1646509A Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 07/27/2005 | CN1646491A Compounds used to prepare camptothecin derivatives |
| 07/27/2005 | CN1644208A China fir extracts with lycopodine A and B composition and their preparing method |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2286914C Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2137623C Phenyl-substituted 1,4-dihydropyridines |
| 07/21/2005 | WO2005066181A1 Process for the preparation of 1,3-dioxolo [4,5-c] piperidin-7-ols and related compounds |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005066128A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | WO2005066127A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | US20050159622 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 07/21/2005 | US20050159455 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159450 Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | US20050156753 Digital sound processing system for a vehicle |
| 07/21/2005 | DE4120550B4 Verfahren zur Herstellung eines gereinigten N,N'-Bis-(2,2,6,6-tetramethyl-4-piperidyl) -alkandiamins A process for producing a purified N, N'-bis (2,2,6,6-tetramethyl-4-piperidyl) -alkandiamins |
| 07/21/2005 | CA2552946A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | CA2552850A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/20/2005 | EP1554267A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554247A2 Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine |
| 07/20/2005 | EP1554246A2 Dihydropyridinone derivatives as hne inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1554242A1 Watersoluble prodrugs of propofol |
| 07/20/2005 | EP1553937A2 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642914A Certain 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor XA |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642535A Tuberculosis treatment using pleuromutilin derivatives |
| 07/20/2005 | CN1211366C Methyl sulfonate trihydrate of 1-(4-hydroxy phenyl)-2-(4-hydroxy-4-phenyl piperid-1-yl)-1-propanol and its intermidiate preparing process |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/19/2005 | US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury |
| 07/19/2005 | US6919481 Alkoxyamines containing a vinyl group, their applications and methods of their production |
| 07/19/2005 | US6919458 Preparation of terfenadine carboxylic acid metabolite and carebastine using a 1-(2-substituted isopropyl)-4-(cyclopropylcarbonyl)-benzene compound intermediate |
| 07/19/2005 | US6919451 Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 07/19/2005 | US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919336 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of IL-1 and TNF |
| 07/14/2005 | WO2005064336A1 Pyrenyloxysulfonic acid fluorescent agents |
| 07/14/2005 | WO2005063714A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 07/14/2005 | WO2005063707A1 Enantiospecific process for the preparation of paroxetine intermediate |
| 07/14/2005 | WO2005063706A1 Synthesis of nojirimycins |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063697A2 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 07/14/2005 | WO2005063680A1 Process for the preparation of arylamines |
| 07/14/2005 | WO2005063678A1 Process for producing phenylacetic acid derivative |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR |
| 07/14/2005 | WO2005046612A3 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/14/2005 | US20050154206 Adjusting pH of solution to generate nitrosonium ion and protonated hydroxylamine, removing solvent, then neutralizing |
| 07/14/2005 | US20050154022 Selective antagonists for melanin concentrating hormone-1 (MCH1) receptors; antidepressants, anxiolytic agents; bipolar, eating, psychological, urogenital, and obsessive-compulsive disorders; phobias, post-traumatic stress disorder |
| 07/14/2005 | US20050154021 N-and O-substituted 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating CNS disorders therewith |
| 07/14/2005 | US20050154020 4-Aryl piperidines |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154017 Novel azasugar derivative and drug containing the same as the active ingredient |
| 07/14/2005 | US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153963 exhibit a particular activity as specific inhibitors of the glycine transporters glyt1 and/or glyt2 |
| 07/14/2005 | US20050153456 Analysis of mass spectral data in the quiet zones |
| 07/14/2005 | CA2550679A1 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1552834A1 Neurotrophic factor production promoter |
| 07/13/2005 | EP1551827A1 Piperidine derivatives as ccr5 inhibitors |
| 07/13/2005 | EP1551805A1 Substituted gamma-phenyl-delta-lactams and uses related thereto |